Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanfranco Pellesi

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Medical Science Educator|January 20, 2026
Trust in AI Feedback: Challenges in Pharmacy EducationLanfranco Pellesi
Expert Opinion on Drug Discovery|July 13, 2023
The human NTG model of migraine in drug discovery and developmentLanfranco Pellesi
The Journal of Headache and Pain|January 31, 2025
Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP successLanfranco Pellesi, Lars Edvinsson
The Journal of Headache and Pain|August 22, 2024
Situational prevention in migraine: are we doing the right thing?Lanfranco Pellesi, Paolo Martelletti
Toxins|October 25, 2024
Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?Lanfranco Pellesi, Dilara Onan, Paolo Martelletti
Clinical Drug Investigation|March 23, 2025
Fremanezumab for the Treatment of Migraine Complicated by Medication Overuse: A Systematic ReviewIbrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Expert Review of Neurotherapeutics|January 24, 2026
Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectivesLanfranco Pellesi, Damiana Scuteri, Paolo Martelletti
Expert Opinion on Emerging Drugs|February 10, 2024
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine preventionLanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Expert Opinion on Pharmacotherapy|May 9, 2024
Pharmacological management of migraine: current strategies and future directionsLanfranco Pellesi, Thien Phu Do, Anders Hougaard
Drug and Alcohol Review|May 19, 2026
Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping ReviewLanfranco Pellesi, Taibah Ali Ahmad, Simona Guerzoni
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Medical Science Educator|January 20, 2026
Trust in AI Feedback: Challenges in Pharmacy EducationLanfranco Pellesi
Expert Opinion on Drug Discovery|July 13, 2023
The human NTG model of migraine in drug discovery and developmentLanfranco Pellesi
The Journal of Headache and Pain|January 31, 2025
Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP successLanfranco Pellesi, Lars Edvinsson
The Journal of Headache and Pain|August 22, 2024
Situational prevention in migraine: are we doing the right thing?Lanfranco Pellesi, Paolo Martelletti
Toxins|October 25, 2024
Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?Lanfranco Pellesi, Dilara Onan, Paolo Martelletti
Clinical Drug Investigation|March 23, 2025
Fremanezumab for the Treatment of Migraine Complicated by Medication Overuse: A Systematic ReviewIbrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Expert Review of Neurotherapeutics|January 24, 2026
Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectivesLanfranco Pellesi, Damiana Scuteri, Paolo Martelletti
Expert Opinion on Emerging Drugs|February 10, 2024
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine preventionLanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Expert Opinion on Pharmacotherapy|May 9, 2024
Pharmacological management of migraine: current strategies and future directionsLanfranco Pellesi, Thien Phu Do, Anders Hougaard
Drug and Alcohol Review|May 19, 2026
Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping ReviewLanfranco Pellesi, Taibah Ali Ahmad, Simona Guerzoni
Pageof 6